|
|
| Key Financial Ratios |
|
| ERIS Lifesciences Ltd | | Industry : Pharmaceuticals - Indian - Formulations | Chairman : Amit Indubhushan Bakshi | | Home : Indian Private | Book Value: 180.2356794 | | BSE Code : 540596 | Market Cap: 11796 | | NSE Code : ERIS | P / E : 33.9 | |
| |
|
|
|
| (Rs in Cr.) |
| Debt-Equity Ratio | 0.08 | 0.00 | 0.00 | 0.07 | 0.27 | | Long Term Debt-Equity Ratio | 0.05 | 0.00 | 0.00 | 0.00 | 0.14 | | Current Ratio | 2.54 | 2.86 | 2.73 | 1.84 | 1.34 | | Fixed Assets | 1.42 | 1.63 | 1.57 | 1.64 | 1.65 | | Inventory | 17.92 | 16.25 | 17.02 | 14.56 | 13.56 | | Debtors | 7.26 | 9.67 | 8.71 | 9.42 | 13.15 | | Interest Cover Ratio | 21.85 | 151.34 | 414.72 | 165.26 | 14.61 | | PBIDTM (%) | 39.27 | 42.20 | 38.55 | 36.31 | 40.85 | | PBITM (%) | 34.41 | 37.97 | 35.16 | 31.91 | 37.33 | | PBDTM (%) | 37.69 | 41.95 | 38.47 | 36.12 | 38.30 | | CPM (%) | 34.77 | 38.55 | 35.01 | 32.95 | 35.35 | | APATM (%) | 29.91 | 34.32 | 31.62 | 28.55 | 31.83 | | ROCE (%) | 19.94 | 25.68 | 26.48 | 24.21 | 25.57 | | RONW (%) | 19.23 | 23.88 | 24.39 | 23.72 | 28.20 |
|
|
|
|
|
|